Shedir Pharma Group S.p.A. (BIT: SHE)

Market Cap	55.45M
Revenue (ttm)	60.96M
Net Income (ttm)	6.00M
Shares Out	11.36M
EPS (ttm)	0.52
PE Ratio	9.30
Forward PE	8.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,500
Average Volume	6,138
Open	4.980
Previous Close	4.880
Day's Range	4.880 - 4.980
52-Week Range	3.340 - 4.980
Beta	0.72
RSI	66.91
Earnings Date	Mar 28, 2025

About Shedir Pharma Group

Shedir Pharma Group S.p.A., through its subsidiaries, engages in the research, formulation, development, and marketing of nutraceuticals, dermocosmetics, medical devices, and pharmaceutical products in Italy. It provides products for andrological, cardiovascular, dermatological, hematological, energy, gastrointestinal, gynecological, metabolic, neurological, dental, ophthalmic, osteoarticular, otologic, respiratory, and trichological diseases. The company offers its products through a network of sales agents, wholesalers, and pharmacies. Shedir...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2008
• Employees: 79
• Stock Exchange: Borsa Italiana
• Ticker Symbol: SHE

Financial Performance

In 2023, Shedir Pharma Group's revenue was 59.39 million, an increase of 11.05% compared to the previous year's 53.48 million. Earnings were 5.62 million, a decrease of -5.18%.